Paydirt
JA
Insider

Jeffrey W. Albers

Director

Jeffrey W. Albers (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BPMC. The largest single filing was $2.4M of SYRE (23,000 sh across 3 lots, as filed), executed Aug 7.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.1M
shares × price, as filed
Last traded
Aug 7
Filed Aug 10

Median ADV $118.2M across their filed names

Open performance
Volume by month
$2.4M$1.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $756KDec 2024 · sells $1.3MJan 2025 · sells $2.1MMar 2025 · sells $1.2MMay 2025 · sells $439KJun 2025 · sells $311KOct 2025 · sells $296KDec 2025 · sells $449KAug 2026 · sells $2.4M
Buys $0 Sells $9.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
BPMC BPMC BPMC · 0 buys · 7 sells 7 filings KYMR Kymera Therapeutics, Inc. KYMR · 0 buys · 3 sells 3 filings SYRE Spyre Therapeutics, Inc. SYRE · 0 buys · 2 sells 2 filings
Recent filings
SYRESALE Spyre Therapeutics, Inc. View filing → $2.4M
23,000 sh across 3 lots
Exec Aug 7
Filed Aug 10 · 9:31 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $449K
5,000 sh across 2 lots
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $296K
5,000 sh × $59.19
Exec Oct 13 2025
Filed Oct 14 2025 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $311K
6,349 sh × $49.00
Exec Jun 3 2025
Filed Jun 3 2025 · 5:30 PM ET
BPMCSALE Blueprint Medicines Corp View filing → $439K
4,350 sh × $101.02
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET
BPMCSALE Blueprint Medicines Corp View filing → $658K
7,500 sh across 2 lots
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET
BPMCSALE Blueprint Medicines Corp View filing → $512K
5,766 sh × $88.80
Exec Mar 5 2025
Filed Mar 17 2025 · 5:30 PM ET †
BPMCSALE Blueprint Medicines Corp View filing → $1.6M
14,961 sh across 2 lots
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET
More filings →